GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Medlive Technology Co Ltd (HKSE:02192) » Definitions » PE Ratio

Medlive Technology Co (HKSE:02192) PE Ratio : 23.11 (As of Dec. 14, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medlive Technology Co PE Ratio?

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-12-14), Medlive Technology Co's share price is HK$9.89. Medlive Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.43. Therefore, Medlive Technology Co's PE Ratio for today is 23.11.

During the past 6 years, Medlive Technology Co's highest PE Ratio was 349.36. The lowest was 16.73. And the median was 55.45.

Medlive Technology Co's EPS (Diluted) for the six months ended in Jun. 2024 was HK$0.21. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.43.

As of today (2024-12-14), Medlive Technology Co's share price is HK$9.89. Medlive Technology Co's EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.43. Therefore, Medlive Technology Co's PE Ratio without NRI ratio for today is 23.16.

During the past 6 years, Medlive Technology Co's highest PE Ratio without NRI was 349.36. The lowest was 16.78. And the median was 55.76.

Medlive Technology Co's EPS without NRI for the six months ended in Jun. 2024 was HK$0.21. Its EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.43.

During the past 12 months, Medlive Technology Co's average EPS without NRI Growth Rate was 50.90% per year. During the past 3 years, the average EPS without NRI Growth Rate was 35.40% per year. During the past 5 years, the average EPS without NRI Growth Rate was 60.90% per year.

During the past 6 years, Medlive Technology Co's highest 3-Year average EPS without NRI Growth Rate was 51.40% per year. The lowest was 35.40% per year. And the median was 48.10% per year.

Medlive Technology Co's EPS (Basic) for the six months ended in Jun. 2024 was HK$0.22. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.43.

Back to Basics: PE Ratio


Medlive Technology Co PE Ratio Historical Data

The historical data trend for Medlive Technology Co's PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlive Technology Co PE Ratio Chart

Medlive Technology Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio
Get a 7-Day Free Trial N/A N/A 349.36 47.92 23.49

Medlive Technology Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only At Loss 47.92 At Loss 23.49 At Loss

Competitive Comparison of Medlive Technology Co's PE Ratio

For the Health Information Services subindustry, Medlive Technology Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medlive Technology Co's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Medlive Technology Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Medlive Technology Co's PE Ratio falls into.



Medlive Technology Co PE Ratio Calculation

The PE Ratio, or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

Medlive Technology Co's PE Ratio for today is calculated as

PE Ratio=Share Price/Earnings per Share (Diluted) (TTM)
=9.89/0.428
=23.11

Medlive Technology Co's Share Price of today is HK$9.89.
For company reported semi-annually, Medlive Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.43.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:


There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Medlive Technology Co  (HKSE:02192) PE Ratio Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratios are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.

PE Ratio can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio.


Medlive Technology Co PE Ratio Related Terms

Thank you for viewing the detailed overview of Medlive Technology Co's PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medlive Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1 Baijialou Chaoyang North Road, E1 Red Manor International Bonded Innovation Park, Chaoyang District, Beijing, CHN
Medlive is a digital healthcare marketing company that produces customized content for pharmaceutical and medical device firms to specifically target physicians through different promotional channels. The company uses in-house and third-party content teams to produce advertising for its clients by profiling the user preferences of the physicians who make procurement and prescription decisions. Its platform also provides medical content consisting of third-party research, informal discussions, and medical news articles. The company also operates a minor internet hospital and SaaS solution that help with medical conferences and clinical research. M3, Japan's leading digital healthcare marketing company owns 38.8% of Medlive through a joint venture.
Executives
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
M3, Inc. 2101 Beneficial owner
Sony Group Corporation 2201 Interest of corporation controlled by you
Tian Liping
Zhang Xiaofeng 2101 Beneficial owner
Liu Lingdi 2101 Beneficial owner
Tian Lixin 2101 Beneficial owner
Brown Brothers Harriman & Co. 2502 Approved lending agent
Fidelity Funds 2101 Beneficial owner
Tiantian Co., Limited

Medlive Technology Co Headlines

No Headlines